National Research: Business Model, SWOT Analysis, and Competitors 2026

National Research Corporation stands as a leading company in Healthcare. Generating $137.39 million in annual revenue (growing -4.6% year-over-year) and carrying a market capitalization of $318.11 million, the company has cemented its position as a foundational player in the global Health Information Services landscape. Under the leadership of its leadership team, National Research Corporation continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines National Research Corporation's business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating National Research Corporation as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define National Research Corporation's position in the Health Information Services market today.

What You Will Learn

1. How National Research Corporation generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering National Research Corporation's competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who National Research Corporation's main competitors are and how the company compares on key financial metrics
4. National Research Corporation's key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. National Research Corporation's strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $137.39 million annual revenue (TTM), +-4.6% YoY
• Market Cap: $318.11 million — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 61.9%, operating margin 13.3%, net margin 8.4%
• Free Cash Flow: $11.37 million
• Return on Equity: 51.2% — strong
• Employees: See latest annual report

Who Owns National Research Corporation?

National Research Corporation is publicly traded on the NMS under the ticker symbol NRC. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of National Research Corporation are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

National Research Corporation has approximately 0.02 billion shares outstanding, with float shares of 0.00 billion — the freely tradeable portion. The stock trades at $14.04 per share as of early 2026.

National Research Corporation's Mission Statement

National Research Corporation's strategic mission is aligned with its core business activities in the Health Information Services sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — National Research Corporation's most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For National Research Corporation, the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, National Research Corporation's strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does National Research Corporation Make Money?

As of 2026, National Research Corporation generates $137.39 million in annual revenue (growing -4.6% year-over-year), with a 61.9% gross margin and 13.3% operating margin. Market capitalization stands at $318.11 million. Here is how the company generates its revenue:

NRC utilizes advanced analytics, machine learning, and artificial intelligence to analyze data and generate actionable insights for healthcare organizations.

What are the future opportunities for NRC?

Future opportunities for NRC include expansion into emerging markets, increasing demand for patient-centric care, strategic partnerships, and the growing telehealth sector.

How can healthcare organizations benefit from NRC's services?

Healthcare organizations can benefit from NRC's insights by improving patient satisfaction, enhancing operational efficiencies, and making data-driven decisions to optimize care delivery.

In 2026, management's strategic priorities center on operational efficiency, market share expansion, and disciplined capital allocation. Investors should review National Research Corporation's latest annual report and quarterly earnings releases for the most current financial disclosures and strategic updates.

National Research Corporation Business Model Canvas

The Business Model Canvas framework provides a structured view of how National Research Corporation creates, delivers, and captures value.

Key Partners: National Research Corporation's key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Health Information Services sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: National Research Corporation's most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: National Research Corporation's critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (N/A employees), proprietary technology, and financial resources ($4.14M in cash).

Value Propositions: National Research Corporation delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Health Information Services market.

Customer Relationships: National Research Corporation maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: National Research Corporation reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: National Research Corporation serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: National Research Corporation's major costs include cost of goods sold (38.1% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 86.7% of revenue.

Revenue Streams: National Research Corporation generates revenue through its core product and service offerings.

National Research Corporation Competitors

National Research Corporation competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Health Information Services segment of the Healthcare sector.

National Research Corporation SWOT Analysis

A SWOT analysis examines National Research Corporation's internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Strong Margins: National Research Corporation's gross margin of 61.9% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of 13.3% demonstrates disciplined cost management even at scale.
• Capital Efficiency: A return on equity of 51.2% demonstrates that National Research Corporation generates strong returns from shareholder capital, a hallmark of companies with durable competitive advantages.

Weaknesses

• High Financial Leverage: With a debt-to-equity ratio of 575.6, National Research Corporation carries significant debt relative to equity. While manageable given its cash flow, elevated leverage limits financial flexibility and increases vulnerability to rising interest rates.
• Revenue Decline: Year-over-year revenue declined 4.6%, raising questions about demand for National Research Corporation's core offerings and requiring management to articulate a credible recovery path.

Opportunities

• Total Addressable Market: National Research Corporation operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for National Research Corporation's products and services.
• Strategic Acquisitions: With $4.14M in cash and strong free cash flow generation, National Research Corporation is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. National Research Corporation's revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on National Research Corporation's business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

National Research Corporation enters 2026 as a leading company in Healthcare, backed by $137.39 million in annual revenue and a 8.4% net profit margin. The company's 61.9% gross margins and $11.37 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in National Research Corporation's core markets.

For investors, National Research Corporation's 28.1x trailing P/E and 12.1x forward P/E reflect the market's expectations for stable earnings. Analysts and investors should watch quarterly earnings releases, management commentary on comparable sales growth, margin trends, and capital allocation for signals of how the investment thesis is progressing.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – National Research, SEC EDGAR – National Research Filings, and National Research's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. What services does NRC provide?

National Research Corporation generated $137.39 million in annual revenue with a 8.4% net profit margin as of the latest reporting period. The company operates in the Health Information Services sector. For the most current information, consult National Research Corporation's investor relations page.

2. Who are NRC's main competitors?

National Research Corporation competes in the Health Information Services segment of the Healthcare sector. The competitor comparison table in this article outlines key peers by market cap, revenue, and margins. Competitive dynamics in Health Information Services center on product differentiation, pricing strategy, and distribution scale.

3. How does NRC use technology in its services?

National Research Corporation generates $137.39 million in annual revenue (TTM) with a 61.9% gross margin, growing -4.6% year-over-year. The company's revenue model is described in detail in the business model section above.

4. What are the future opportunities for NRC?

National Research Corporation's key growth opportunities include: National Research Corporation operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Nationa With $4.14M in cash and strong free cash flow generation, National Research Corporation is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic r

5. How can healthcare organizations benefit from NRC's services?

National Research Corporation generated $137.39 million in annual revenue with a 8.4% net profit margin as of the latest reporting period. The company operates in the Health Information Services sector. For the most current information, consult National Research Corporation's investor relations page.